Acinetobacter baumannii is an important nosocomial pathogen that causes a range of diseases, including respiratory and urinary tract infections, meningitis, endocarditis, wound infections, and bacteremia. In fact, A. baumannii is now responsible for up to 20% of all intensive care unit infections in some regions of the world with pneumonia being the most common presentation. The clinical significance of A. baumannii has been propelled by this organism's rapid acquisition of resistance to virtually all antibiotics. The identification of novel targets for therapeutic intervention is critical to our ability to protect he public health from this emerging infectious threat. One promising potential area of therapeutic development involves targeting bacterial access to nutrient metal. This strategy is based on the fact that all bacterial pathogens require nutrient metal in order to colonize their hosts. Despite the fact that a variety of metals are required by bacterial pathogens during growth within vertebrates, iron sequestration is considered to be the primary nutrient that is actively sequestered by the host during the innate immune response to infection. In the present application, we provide evidence that the innate immune factor calprotectin defends against Acinetobacter pneumonia by chelating nutrient zinc (Zn). Using calprotectin as a probe, we have identified a transport system in A. baumannii that competes with calprotectin for Zn and is transcriptionally controlled by a Zn-dependent regulator. Calprotectin is abundant at sites of inflammation and is a known pro- inflammatory molecule that is a ligand for the receptor for advanced glycation end products (RAGE). Despite its clear involvement, the contributions of calprotectin-mediated metal sequestration and RAGE binding to defense against infection have not been thoroughly evaluated. Based on preliminary data described in this application, we hypothesize that calprotectin-mediated Zn sequestration and RAGE binding are critical factors during the host-pathogen interaction. To test this central hypothesis, we propose a series of experiments aimed at understanding the mechanism and pathophysiological consequence of calprotectin-mediated Zn sequestration and RAGE binding during A. baumannii pneumonia. In these studies, we will (i) identify the structural features of calprotectin that enable it to chelae transition metals such as Zn and to bind RAGE, (ii) elucidate the impact of calprotectin and RAGE on A. baumannii pathogenesis, and (iii) determine the impact of CP-mediated Zn chelation on the physiology of A. baumannii. These results will provide fundamental insight into how A. baumannii acquires nutrients in the vertebrate host, and lay the foundation for the creation of peptide therapeutics based on a calprotectin scaffold that inhibit microbial growth through nutrient metal chelation.

Public Health Relevance

This application has the potential to lead to the development of calprotectin-based therapies to treat microbial infections. Calprotectin is active against numerous bacterial and fungal pathogens, ensuring that these studies will have broad applicability across a variety of infectious agents. Further, this work will uncover new principles in metal biology that may lay the groundwork for the design of intervention measures to protect the public health from emerging infectious threats.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Host Interactions with Bacterial Pathogens Study Section (HIBP)
Program Officer
Korpela, Jukka K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
Schools of Medicine
United States
Zip Code
Lopez, Christopher A; Skaar, Eric P (2018) The Impact of Dietary Transition Metals on Host-Bacterial Interactions. Cell Host Microbe 23:737-748
Cassat, James E; Moore, Jessica L; Wilson, Kevin J et al. (2018) Integrated molecular imaging reveals tissue heterogeneity driving host-pathogen interactions. Sci Transl Med 10:
Aranda, Carlos J; Ocón, Borja; Arredondo-Amador, María et al. (2018) Calprotectin protects against experimental colonic inflammation in mice. Br J Pharmacol 175:3797-3812
Lentz, Christian S; Sheldon, Jessica R; Crawford, Lisa A et al. (2018) Identification of a S. aureus virulence factor by activity-based protein profiling (ABPP). Nat Chem Biol 14:609-617
Besold, Angelique N; Culbertson, Edward M; Nam, Lily et al. (2018) Antimicrobial action of calprotectin that does not involve metal withholding. Metallomics :
Noto, Michael J; Becker, Kyle W; Boyd, Kelli L et al. (2017) RAGE-Mediated Suppression of Interleukin-10 Results in Enhanced Mortality in a Murine Model of Acinetobacter baumannii Sepsis. Infect Immun 85:
Kinsella, Rachel L; Lopez, Juvenal; Palmer, Lauren D et al. (2017) Defining the interaction of the protease CpaA with its type II secretion chaperone CpaB and its contribution to virulence in Acinetobacter species. J Biol Chem 292:19628-19638
Garcia, Yuritzi M; Barwinska-Sendra, Anna; Tarrant, Emma et al. (2017) A Superoxide Dismutase Capable of Functioning with Iron or Manganese Promotes the Resistance of Staphylococcus aureus to Calprotectin and Nutritional Immunity. PLoS Pathog 13:e1006125
Aron, Allegra T; Heffern, Marie C; Lonergan, Zachery R et al. (2017) In vivo bioluminescence imaging of labile iron accumulation in a murine model of Acinetobacter baumannii infection. Proc Natl Acad Sci U S A 114:12669-12674
Besold, Angelique N; Gilston, Benjamin A; Radin, Jana N et al. (2017) The role of calprotectin in withholding zinc and copper from Candida albicans. Infect Immun :

Showing the most recent 10 out of 43 publications